These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23118671)

  • 1. Acute intoxication caused by a synthetic cannabinoid in two adolescents.
    Heath TS; Burroughs Z; Thompson AJ; Tecklenburg FW
    J Pediatr Pharmacol Ther; 2012 Apr; 17(2):177-81. PubMed ID: 23118671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.
    McKeever RG; Vearrier D; Jacobs D; LaSala G; Okaneku J; Greenberg MI
    J Med Toxicol; 2015 Mar; 11(1):129-31. PubMed ID: 25154434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction associated with use of the synthetic cannabinoid K2.
    Mir A; Obafemi A; Young A; Kane C
    Pediatrics; 2011 Dec; 128(6):e1622-7. PubMed ID: 22065271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Cannabinoids in Prisons: Content Analysis of TikToks.
    McMann TJ; Calac A; Nali M; Cuomo R; Maroulis J; Mackey TK
    JMIR Infodemiology; 2022; 2(1):e37632. PubMed ID: 37113804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - A case series.
    Andonian DO; Seaman SR; Josephson EB
    Am J Emerg Med; 2017 Jun; 35(6):940.e5-940.e6. PubMed ID: 28238395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.
    Babi MA; Robinson CP; Maciel CB
    SAGE Open Med Case Rep; 2017; 5():2050313X17745206. PubMed ID: 29238581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Cannabinoids.
    Mills B; Yepes A; Nugent K
    Am J Med Sci; 2015 Jul; 350(1):59-62. PubMed ID: 26132518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How much can synthetic cannabinoid damage the heart? A case of cardiogenic shock following resistant ventricular fibrillation after synthetic cannabinoid use.
    Yamanoglu A; Celebi Yamanoglu NG; Evran T; Sogut O
    J Clin Ultrasound; 2018 Nov; 46(9):605-609. PubMed ID: 29479764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.
    Zaurova M; Hoffman RS; Vlahov D; Manini AF
    J Med Toxicol; 2016 Dec; 12(4):335-340. PubMed ID: 27255136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Thrombocytopenic Purpura Induced by Synthetic Cannabinoid.
    Castaneira G; Rojas K; Galili Y; Field Z; Perez-Perez A; Madruga M; Carlan SJ
    J Addict Med; 2019; 13(3):235-236. PubMed ID: 30531235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients.
    Clark BC; Georgekutty J; Berul CI
    J Pediatr; 2015 Sep; 167(3):757-61.e1. PubMed ID: 26165442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
    Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
    Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.
    Keyes KM; Rutherford C; Hamilton A; Palamar JJ
    Drug Alcohol Depend; 2016 Sep; 166():159-67. PubMed ID: 27491817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
    Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
    Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Cannabinoid-Associated Multiple Organ Failure: Case Series and Literature Review.
    Armstrong F; McCurdy MT; Heavner MS
    Pharmacotherapy; 2019 Apr; 39(4):508-513. PubMed ID: 30811628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.